EP4203963
COMBINATION THERAPY OF NAPORAFENIB AND TRAMETINIB FOR USE IN THE TREATMENT OF SARCOMA
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
30.8.2021EP published:
21.1.2026EP application number:
21765720.4
EPO information:
European Patent Register
Max expiry date:
29.8.2041Expiry date:
29.8.2026
Title in English:
COMBINATION THERAPY OF NAPORAFENIB AND TRAMETINIB FOR USE IN THE TREATMENT OF SARCOMALanguage of the patent:
English
Timeline
Today
30.8.2021EP application
21.1.2026EP Publication
29.8.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
Board of Regents, The University of Texas SystemAddress:
210 West 7th Street, Austin, TX 78701, US
Inventor
Name:
CAPONIGRO, GiordanoAddress:
Cambridge, Massachusetts 02139, US
Name:
COOKE, VesselinaAddress:
Cambridge, Massachusetts 02139, US
Name:
VASEVA, AngelinaAddress:
San Antonio, Texas 78229, US
Priority
Number:
202063072528 PDate:
31.8.2020Country:
US
Classification
Categories:
A61K 31/519, A61K 31/5377, A61K 45/06, A61P 35/00